Trials / Completed
CompletedNCT02619539
Shock Index To DEtect Low Plasma Fibrinogen In Trauma (SIDE)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 280 (actual)
- Sponsor
- Masaryk Hospital Krajská zdravotní a.s. · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Shock-index is potentially an easy tool to estimate the risk of hypofibrinogenemia without the need to perform other potentially time consuming investigations.
Detailed description
Hypofibrinogenemia is common in severe trauma and below the threshold of 2.3 g/l is associated with increased mortality. Although guidelines for management of the trauma induced coagulopathy does not recommend any specific timing of fibrinogen substitution, several papers suggest that early substitution might be associated with improved outcome. Laboratory measurement of plasma fibrinogen level, thromboelastometry and/or its estimation based on base excess, hemoglobin level, Injury Severity Score or combinations require diagnostic procedures that are associated with with a certain time delay and prolongs the time to fibrinogen substitution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | plasma fibrinogen measurement | plasma fibrinogen measurement |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2017-02-28
- Completion
- 2017-02-28
- First posted
- 2015-12-02
- Last updated
- 2017-03-24
Locations
2 sites across 1 country: Czechia
Source: ClinicalTrials.gov record NCT02619539. Inclusion in this directory is not an endorsement.